Abpro Holdings, Inc. (ABP)
NASDAQ: ABP · Real-Time Price · USD
0.2584
-0.0395 (-13.26%)
At close: Jul 31, 2025, 4:00 PM
0.2540
-0.0044 (-1.70%)
After-hours: Jul 31, 2025, 5:10 PM EDT

Verve Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20172019 - 2020
Period Ending
Jul '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '17 2019 - 2020
1690146141--
Upgrade
Market Cap Growth
-78.96%-38.12%3.83%---
Upgrade
Enterprise Value
18174168163--
Upgrade
Last Close Price
0.301.7910.5810.19--
Upgrade
PS Ratio
51.03494.191197.8469.37--
Upgrade
PB Ratio
--6.05-11.38-1042.59--
Upgrade
EV/Sales Ratio
99.55950.031376.4780.11--
Upgrade
Debt / Equity Ratio
-0.18-0.22-0.22-13.880.18-
Upgrade
Asset Turnover
-0.050.020.21-0.18
Upgrade
Quick Ratio
0.080.160.050.861.485.61
Upgrade
Current Ratio
0.110.190.130.891.545.71
Upgrade
Return on Equity (ROE)
----1172.68%--125.45%
Upgrade
Return on Assets (ROA)
--154.71%-96.55%-105.66%--62.21%
Upgrade
Return on Capital (ROIC)
----388.53%--78.60%
Upgrade
Earnings Yield
-133.13%-8.00%-8.01%-12.23%--
Upgrade
FCF Yield
-48.68%-9.98%-5.10%-6.36%--
Upgrade
Buyback Yield / Dilution
-45.17%-22.35%-105.48%-0.40%21.18%-1.10%
Upgrade
Updated Dec 23, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q